Investing.com - Merck reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €1.50 on revenue of €4.12B. Analysts polled by Investing.com anticipated EPS of €1.36 on revenue of €4.1B.
Merck shares are down 7% from the beginning of the year, still down 10.20% from its 52 week high of €125.95 set on February 20. They are outperforming the STOXX 600 which is down 12.83% from the start of the year.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings beat by Siemens AG on Thursday, who reported EPS of €1.12 on revenue of €13.49B, compared to forecasts EPS of €0.43 on revenue of €12.57B.
Bayer had beat expectations on Tuesday with second quarter EPS of €2.67 on revenue of €10.05B, compared to forecast for EPS of €1.5 on revenue of €10.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar